Device Trial Radar · NCT06533774
Speech Locator_Benefits in Pediatric Popluations
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
27
Actual
Start
Jun 8, 2023
Primary completion
Oct 31, 2023
Study completion Oct 31, 2023
Sponsor
- Lead sponsor
- Sonova AGNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 1, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 10 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study seeks to evaluate the impact of SpeechSensor and StereoZoom 2.0 on speech understanding in noise in dynamic listening conditions in pediatric hearing aid users.
Conditions
- Hearing Loss
Interventions
Phonak Audéo Lumity 90-RDevice
This study will be using the Audeo L90-R devices, which are programmed by the hearing care professional (HCP) using Target fitting software version 8.1.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Speech intelligibility using AZBio sentences Verbal response accuracy based on percent of words correctly repeated on an open-set sentence recognition in noise task.Time frame: 3 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hearts for Hearing
Oklahoma City, Oklahoma
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.